Noctiva (desmopressin)
/ CPEX, Avadel, Serenity Pharma, AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 12
Of
12
Go to page
1
November 22, 2020
Pancreas-specific SNAP23 Depletion Prevents Pancreatitis by Attenuating Pathological Basolateral Exocytosis and Formation of Trypsin-activating Autolysosomes.
(PubMed, Autophagy)
- "This SNAP23 relocation was attributed to IKBKB/IKKβ-mediated SNAP23 phosphorylation at Ser95 Ser120 in rat and Ser120 in human, which was blocked by IKBKB/IKKβ inhibitors, and confirmed by the inability of IKBKB/IKKβ phosphorylation-disabled SNAP23 mutant (Ser95A Ser120A) to bind STX17 SNARE complex...This study revealed the roles of SNAP23 in mediating pathological basolateral exocytosis and IKBKB/IKKβ's involvement in autolysosome formation, both where trypsinogen activation would occur to cause pancreatitis. SNAP23 is a strong candidate to target for pancreatitis therapy."
Journal • Pancreatitis • NFKB1
June 11, 2020
GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single-center, randomized clinical trial.
(PubMed, Low Urin Tract Symptoms)
- "Both laser systems provided comparable improvement in the subjective and objective parameters with excellent hemostatic properties. Although our results suggest that both procedures are useful treatment choices, further follow-up is needed to draw definitive conclusions regarding the most ideal laser for treating patients with symptomatic BPH."
Clinical • Journal • Benign Prostatic Hyperplasia
February 27, 2016
A glycosynthase derived from an inverting chitinase with an extended binding cleft.
(PubMed)
-
J Biochem
- "However, the double mutant E89G/S120A, of which the hydrolytic activity was completely abolished while its F(-)-releasing activity was only moderately affected, produced the largest amount of (GlcNAc)7 from α-(GlcNAc)3-F and (GlcNAc)4 without decomposition. We concluded that E89G/S120A was an efficient glycosynthase, that enabled the addition of a three-sugar unit."
Journal • Biosimilar
March 02, 2017
Insights from the analysis of predicted Rv0679c protein peptide from Mycobacterium tuberculosis with Toll like Receptors in host.
(PubMed)
-
Bioinformation
- "Interactive residue analysis revealed that GLU 173 and SER 454 of TLR 1; ARG 447 and ARG 486 of TLR2; ARG 264 of TLR 4 and SER 120, LYS 122 and GLU 92 of MD2 region are predominant residues interacting with peptides of Rv0679c protein. Our study suggests that predominant residues and receptors of TLR2 and TLR4 are important for Rv0679c protein binding, which could further lead to invasion of M. tb into the host cell."
Journal • Biosimilar
March 01, 2019
Structural and Functional Characterization of Sulfonium Carbon-Oxygen Hydrogen Bonding in the Deoxyamino Sugar Methyltransferase TylM1.
(PubMed, Biochemistry)
- "Correlatively, quantum mechanical calculations of the activation barrier energies of WT TylM1 and the Tyr14 mutants suggest that substitutions which abrogate hydrogen bonding with the AdoMet methyl group impair methyl transfer. Together, these results offer insights into roles of CH•••O hydrogen bonding in modulating the catalytic efficiency of TylM1."
Journal
May 16, 2019
Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance.
(PubMed, Am J Physiol Endocrinol Metab)
- "Further, single (Ser312Ala) and double (Ser312Ala+Ser120Ala) phosphorylation-defective Fet-A mutants were without effect on glucose uptake and glycogen synthesis in L6GLUT4 myoblasts. Together, our studies demonstrate that phosphorylation status of fetuin-A (Ser312) is associated with obesity and insulin resistance, and raise the possibility that fetuin-A phosphorylation may play a role in regulation of insulin action."
Journal
February 21, 2020
Congenital hypogonadotropic hypogonadism with anosmia and Gorlin features caused by a PTCH1 mutation reveals a new candidate gene for Kallmann syndrome.
(PubMed, Neuroendocrinology)
- "This family suggests that the two main signs of KS can be included in GGS associated with PTCH1 mutations. Our data combined with mice models suggest that PTCH1 could be a novel candidate gene for KS/CHH and reinforce the role of the Hedgehog signaling pathway in pathophysiology of KS and GnRH neuron migration."
Journal • MRI • PTCH1 • SOX10
June 12, 2019
Characterization of the pleiotropic LysR-type transcription regulator LeuO of Escherichia coli.
(PubMed, Nucleic Acids Res)
- "The data suggest that LeuO-S120D mimics an effector-induced form of LeuO regulating a distinct set of target loci. In general, constitutive mutants and determining the DNA-binding specificity of the DBD-dimer are feasible approaches to characterize LTTRs of unknown function."
Journal
April 18, 2019
Inhibitory effect of flavonoids from Scutellariae Radix on human cytochrome P450 1A
(PubMed, Zhongguo Zhong Yao Za Zhi)
- "Molecular docking demonstrated that wogonin could strongly interact with CYP1 A1 and CYP1 A2 via hydrophobic and π-π interactions, as well as Ser120 and Ser116 in CYP1 A1 via hydrogen-bonding. In conclusion, this study found that some flavonoids in Scutellariae Radix displayed a strong inhibitory effect on CYP1 A, while wogonin is the most potent CYP1 A inhibitor with a relatively high selectivity towards CYP1 A over other human CYPs."
Journal
June 14, 2019
Altered adhesion of dental sealant to tooth enamel microscopically modified by Er:YAG laser irradiation: An in vitro study.
(PubMed, Laser Ther)
- "Despite the presence of cracks after Er:YAG laser application, dissolution of enamel substances was limited. Our study has shown a reduced shear bond strength of dental sealant to an Er:YAG laser-irradiated enamel, compared with phosphoric acid-etched enamel."
Journal • Preclinical
May 01, 2019
Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects.
(PubMed, Pharm Res)
- "AV002 demonstrated rapid absorption, high bioavailability, limited duration of action, and low coefficient of variation, suggesting it may be a suitable formulation for nocturia treatment. Trial registration not required (single-center, phase 1)."
Clinical • Journal • PK/PD data
February 07, 2019
Synchronous Ovarian and Breast Cancers with a Novel Variant in BRCA2 Gene: A Case Report.
(PubMed, Case Rep Oncol Med)
- "...Due to her synchronic breast and ovarian cancers, a genetic profile was performed detecting a new pathogenic variant in the BRCA2 gene: c.3606_3607del (p.Ser1203Cysfs). She was given chemotherapy with carboplatin and paclitaxel obtaining complete clinical response. Regarding her breast cancer, she had a right modified radical mastectomy and prophylactic left mastectomy obtaining complete clinical response. This case presents with an unusual subtype and difficult histologic diagnosis of a synchronic medullar breast cancer and ovary carcinoma associated with a new mutation of the BRCA2 gene."
BRCA Biomarker • Clinical • Journal
1 to 12
Of
12
Go to page
1